1. 28LBA A phase 1 study of PF-06647020, an antibody-drug conjugate targeting PTK7, in patients with advanced solid tumors. (September 2015) Authors: Tolcher, A.W.; Calvo, E.; Maitland, M.L.; Gibson, B.; Xuan, D.; Joh, T.; Jackson-Fischer, A.; Damelin, M.; Barton, J.; Xin, X.; Sachdev, J.C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First-in-human safety, pharmacokinetics, and preliminary efficacy of TPX-0022, a novel inhibitor of MET/SRC/CSF1R in patients with advanced solid tumors harboring genetic alterations in MET. (October 2020) Authors: Hong, D.; Bazhenova, L.; Cho, B.C.; Sen, S.; Ponz-Sarvise, M.; Heist, R.; Zimmerman, Z.; Le, X.; Xuan, D.; Junming, Z.; Lee, J. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Periodontitis contributes to aberrant metabolism in type 2 diabetes mellitus rats by stimulating the expression of adipokines. (12th October 2015) Authors: Luo, S.; Yang, X.; Wang, D.; Ni, J.; Wu, J.; Xu, Z.; Xuan, D.; Zhang, J. Journal: Journal of periodontal research Issue: Volume 51:Number 4(2016) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗